Eliquis Lawsuit | Eliquis Bleeding Side Effects Lawsuit
Eliquis Lawsuits, Eliquis Attorney | Eliquis Side Effects Lawsuit, Eliquis Bleeding Side Effects Lawsuit | Eliquis Lawsuit | Eliquis Internal Bleeding, Eliquis Gastrointestinal Bleeding, Eliquis Hemorrhagic Stroke, Eliquis Death; Eliquis Bleeding | Side Effects: Internal Bleeding, Hemorrhaging, Deep Vein Thrombosis, Pulmonary Embolism
Alonso Krangle LLP is investigating Eliquis bleeding lawsuits on behalf of patients or their survivors who used the blood thinner and experienced serious bleeding or other complications from the prescription medication manufactured by The Bristol-Myers Squibb Company. Eliquis, like other blood thinners, reduces blood clotting but increases the risk of serious bleeding.
You may be entitled to file an Eliquis lawsuit claim if you or your loved one experienced such side effects as:
- Uncontrolled bleeding
- Gastrointestinal bleeding
- Hemorrhagic stroke (bleeding within the brain)
- Intracranial hemorrhage (bleeding inside the skull)
- Blood clots
Eliquis, like other blood thinners, reduces blood clotting but increases the risk of serious bleeding. If you would like a free legal evaluation of your Eliquis lawsuit claim, contact our law firm at 1-800-403-6191 or fill out the form on the right on our webpage.
Eliquis FDA approval Uses
Eliquis (apixaban) was approved in 2012 by the U.S. Food and Drug Administration (FDA) to reduce the risk of stroke and dangerous blood clots (systemic embolism) in patients with atrial fibrillation (abnormal heart rhythm) that is not caused by a heart valve problem. The oral blood thinner is manufactured by Bristol-Myers Squibb Company (BMS), based in Princeton, N.J. and marketed by BMS and Pfizer Inc. of New York. The FDA expanded approval of Eliquis in 2014 to treat deep vein thrombosis (blood clot formed in a vein deep in the body, usually in the legs) and pulmonary embolism (blood clot in lungs) in patients who have had hip or knee replacement surgery. According to BMS’ 2014 annual report, Eliquis sales rose by $628 million following its global launch in 2013 to total $774 million.
[fdanews.com/articles/163138-fda-approves-eliquis-snda, March 17, 2014] [investor.bms.com/files/doc_financials/annual%202014/BMS-2014-10K.pdf, December 31, 2014]
Eliquis, along with Xarelto (rivaroxaban) and Pradaxa (dabigatran) are considered next generation blood thinners because they were developed as newer alternatives to warfarin, (Coumadin, Jantoven) an older blood thinner which the FDA approved in 1954. Eliquis and the other next generation anticoagulants have been promoted as being superior to warfarin in that patients taking the newer drugs do not need routine blood testing, as do patients who take warfarin. However, the new generation blood thinners do not have antidotes to reverse the medications’ effects should severe bleeding occur in patients taking the blood thinners. Warfarin uses vitamin K to reverse internal bleeding episodes. BMS, Pfizer and Portola Pharmaceuticals announced that they are working together to develop an antidote for Eliquis. [fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm333634.htm, December 28, 2012]
[globenewswire.com/news-release/2015/01/09/696279/10114858/en/Portola-Announces-Phase-3-ANNEXA-R-Study-of-Andexanet-Alfa-and-Factor-Xa-Inhibitor-XARELTO-R-rivaroxaban-Met-Primary-Endpoint-With-High-Statistical-Significance.html, January 9, 2015]
Eliquis Side-Effects Including Serious Internal Bleeding
While serious bleeding is a commonly reported side-effect of Eliquis, other side-effects of the blood thinner include:
- Red, pink, or brown urine
- Red or black stools (looks like tar)
- Coughing up blood or blood clots
- Vomit blood or vomit that looks like coffee grounds
- Unexpected pain, swelling or joint pain
- Headaches, dizziness or weakness
[packageinserts.bms.com/pi/pi_eliquis.pdf, August 2014]
In September 2011, a study published in the New England Journal of Medicine found that Eliquis was superior to warfarin in preventing stroke or systemic embolism, caused less bleeding and had a lower mortality rate than the older blood thinner. Another study published two years later in the New England Journal of Medicine found Eliquis to be noninferior to conventional therapy with the anticoagulant enoxaparin (Lovenox, Clexane) and a vitamin K antagonist (that reduces blood clotting by reducing the action of vitamin K) in patients with acute venous thromboembolism. The study, published in August 2013, also associated Eliquis with a 69 percent reduction in major bleeding events. In August 2014, a study published in the Journal of Neurosurgery on newer anticoagulants, including Eliquis, noted that the medications still do not have a specific antidote to reverse the effects of the blood thinners.
[nejm.org/doi/full/10.1056/NEJMoa1107039#t=articleDiscussion, September 15, 2011] [nejm.org/doi/full/10.1056/NEJMoa1302507#t=articleDiscussion, August 29, 2013]
[thejns.org/doi/full/10.3171/2014.8.paradigm, August 2014]
Eliquis Lawsuit Litigation Due to Serious Bleeding Side Effect
Eliquis bleeding side effects lawsuits are being filed against Bristol-Meyers-Squibb and Pfizer claiming the blood thinner causes significant bleeding and deep vein thrombosis. The plaintiffs allege that the companies failed to disclose to emergency room physicians, the medical community and to the general public that there is no antidote to reverse the effects of the blood thinner should bleeding occur in patients who take the medication. Eliquis bleeding side effects lawsuits complaints are also being filed on behalf of individuals who died due to complications from bleeding episodes allegedly as a result of using the blood thinner.
About Alonso Krangle LLP And Filing An Eliquist Lawsuit for Bleeding Side-Effects
Andres Alonso and David Krangle, attorneys with almost 40 years of collective legal experience, have focused their law practice on the handling of significant personal injury cases, defective drug and medical device litigation, construction site accidents, nursing home abuse, medical malpractice, whistleblower actions and consumer fraud cases. A national law firm representing injured victims throughout the U.S., Alonso Krangle LLP is headquartered in Long Island, New York, with offices in New York City and New Jersey. Alonso Krangle LLP continues to offer free Eliquis Lawsuit reviews for serious bleeding side-effects. If you would like a legal review of your Eliquis lawsuit claim, please contact the firm at 1-800-403-6191 or visit www.FightForVictims.com.